INS and diabetes mellitus: The management of iatrogenic diabetes in this setting was previously addressed in a dedicated phase IV study (42) that recommended the use of incretin-based drugs along with metformin, considering the underlying pathophysiology of pasireotide-related diabetes (14, 43), with insulin reserved as a rescue measure.